< Back to latest news & events

Event

LSPN North America 2023

August 2023

HGF are gold sponsors of the LSPN North America Fall event, due to go ahead in San Francisco from 10th-11th October 2023.

This two day event will focus on the latest regulatory developments in the life sciences. You will gain insight into the sector issues of importance and listen to industry experts share their views. This event will be interactive so you can take part in smaller discussion groups to share opinions and views on different topics. You will have the opportunity to put questions to the speakers and panelists, whilst also networking with other IP professionals.

HGF Partner and Patent Attorney, Andrew Camenisch and Patent Director, Punita Shah will be speaking at the event on ‘European IP landscape – (1) the latest Enlarged Board of Appeal decision and (2) the UPC in the “cold light of day”’.

Here is the synopsis of Andrew and Punita’s speech:

“In March this year, Europe saw dawn of the Unified Patent Court and the issuance of the England Board of Appeal Decision relating to the use of post-published evidence to support inventive step.

In their presentation, Andy and Punita will discuss how Europe’s patenting and litigation landscape is changing as the first set of orders and cases before the UPC emerge. The talk will highlight emerging trends in the use of the UPC, and lessons we can learn from early users of the new system.

The concept of plausibility has caused great controversy in European patent law in recent years. The issuance of the Enlarged Board of Appeal decision was eagerly awaited, in the hope that it would bring clarity to this issue. Andy and Punita will discuss the impact of the decision, and whether it does in fact bring any legal certainty to the issue of plausibility in Europe.”

Patent Director, Ellie Purnell will also be attending the event.

The full agenda for the event can be viewed here.

Click the button below to find out more and register:

Latest updates

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

WIPR Diversity Top 100 2025

HGF’s European Patent Attorney Alexandra Wood has been listed in World IP Review’s (WIPR) Diversity Top 100 2025 World IP Review’s Diversity in IP listings 2025 recognises and celebrates people …

Read article

INTA 2025 Annual Meeting Live

The HGF European team will be attending the INTA Annual Meeting Live, which will take place on 17th-21st May in San Diego, US. The conference will connect some of the …

Read article

HGF wins big at the Managing IP EMEA Awards Ceremony 2025

The Annual Managing IP Awards: EMEA Awards 2025 were announced last night, and HGF are proud to have won 7 awards. The Managing IP Awards are highly recognised and respected …

Read article

Plant Patent Infringement in the US Relies on Evidence of Asexual Reproduction

A recent case in the US District Court for the Northern District of Texas (Dallas Division) once again highlights how important the initial pleadings and evidence in patent infringement cases …

Read article

Exam Success at HGF!

HGF is pleased to announce that several of our attorneys have passed their UK Advanced Patent exams! In no specific order, we would like to say well done and a …

Read article

IP Ingredients: How food companies are using IP to stay ahead of the GLP-1 curve

The impact of GLP-1 on the food and beverage sector GLP-1 agonists, best-known under the brand names Ozempic® and Wegovy®, are medicines used to treat type 2 diabetes and obesity. …

Read article